Tri Nguyen

Dr. Tri Nguyen

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
WPWarangkana Pichaiwong
Warangkana Pichaiwong
KHKelly L. Hudkins
Kelly L. Hudkins
TWTomasz Wietecha
Tomasz Wietecha
TNTri Nguyen
Tri Nguyen
CTChiraporn Tachaudomdach
Chiraporn Tachaudomdach
CACharles E. Alpers
Charles E. Alpers
The reversibility of diabetic nephropathy remains controversial. Here, we tested whether replacing leptin could reverse the advanced diabetic nephropathy modeled by the leptin-deficient BTBR ob/ob mouse. Leptin replacement, but not inhibition of the renin-angiotensin-aldosterone system (RAAS), resulted in near-complete reversal of both structural (mesangial matrix expansion, mesangiolysis, basement membrane thickening, podocyte loss) and functional (proteinuria, accumulation of reactive oxygen species) measures of advanced diabetic nephropathy. Immunohistochemical labeling with the podocyte markers Wilms tumor 1 and p57 identified parietal epithelial cells as a possible source of regenerating podocytes. Thus, the leptin-deficient BTBR ob/ob mouse provides a model of advanced but reversible diabetic nephropathy for further study. These results also suggest that restoration of lost podocytes is possible but is not induced by RAAS inhibition, possibly explaining the limited efficacy of RAAS inhibitors in promoting repair of diabetic nephropathy.

14 October 2014 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
HKHelena M. Kok
Helena M. Kok
LFLucas L. Falke
Lucas L. Falke
RGRoel Goldschmeding
Roel Goldschmeding
TNTri Nguyen
Tri Nguyen

30 November 2010 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
JLJan Willem Leeuwis
Jan Willem Leeuwis
TNTri Nguyen
Tri Nguyen
ADAmélie Dendooven
Amélie Dendooven
RKRobbert J. Kok
Robbert J. Kok
RGRoel Goldschmeding
Roel Goldschmeding

1 November 2008 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
TNTri Nguyen
Tri Nguyen
PRPeggy Roestenberg
Peggy Roestenberg
FNFrans A. Van Nieuwenhoven
Frans A. Van Nieuwenhoven
NBNiels Bovenschen
Niels Bovenschen
ZLZeke Li
Zeke Li
RGRoel Goldschmeding
Roel Goldschmeding
In diabetic nephropathy, connective tissue growth factor (CTGF) is upregulated and bone morphogenetic protein 7 (BMP-7) is downregulated. CTGF is known to inhibit BMP-4, but similar cross-talk between BMP-7 and CTGF has not been studied. In this study, it was hypothesized that CTGF acts as an inhibitor of BMP-7 signaling activity in diabetic nephropathy. Compared with diabetic wild-type CTGF+/+ mice, diabetic CTGF+/− mice had approximately 50% lower CTGF mRNA and protein, less severe albuminuria, no thickening of the glomerular basement membrane, and preserved matrix metalloproteinase (MMP) activity. Although the amount of BMP-7 mRNA was similar in the kidneys of diabetic CTGF+/+ and CTGF+/− mice, phosphorylation of the BMP signal transduction protein Smad1/5 and expression of the BMP target gene Id1 were lower in diabetic CTGF+/+ mice. Moreover, renal Id1 mRNA expression correlated with albuminuria (R = −0.86) and MMP activity (R = 0.76). In normoglycemic mice, intraperitoneal injection of CTGF led to a decrease of pSmad1/5 in the renal cortex. In cultured renal glomerular and tubulointerstitial cells, CTGF diminished BMP-7 signaling activity, evidenced by lower levels of pSmad1/5, Id1 mRNA, and BMP-responsive element–luciferase activity. Co-immunoprecipitation, solid-phase binding assay, and surface plasmon resonance analysis showed that CTGF binds BMP-7 with high affinity (Kd approximately 14 nM). In conclusion, upregulation of CTGF inhibits BMP-7 signal transduction in the diabetic kidney and contributes to altered gene transcription, reduced MMP activity, glomerular basement membrane thickening, and albuminuria, all of which are hallmarks of diabetic nephropathy.

27 August 2010 in International Journal of Experimental Pathology
Verified
Journal Article
Closed access
PDF file
ADAmélie Dendooven
Amélie Dendooven
DJDavid A. Ishola Jr
David A. Ishola Jr
TNTri Nguyen
Tri Nguyen
DGDionne M. Van der Giezen
Dionne M. Van der Giezen
RKRobbert Kok
Robbert Kok
JJJaap A. Joles
Jaap A. Joles

1 April 2012 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
JJJohn A. Jansen
John A. Jansen
TVToon A.B. van Veen
Toon A.B. van Veen
SJSanne de Jong
Sanne de Jong
RNRoel van der Nagel
Roel van der Nagel
LSLeonie van Stuijvenberg
Leonie van Stuijvenberg
HRHarold V.M. van Rijen
Harold V.M. van Rijen
Background—: Arrhythmogenic ventricular remodeling is hallmarked by both reduced gap junction expression and increased collagen deposition. We hypothesized that reduced connexin43 (Cx43) expression is responsible for enhanced fibrosis in the remodeled heart, resulting in an arrhythmogenic substrate. Therefore, we investigated the effect of normal or reduced Cx43 expression on the formation of fibrosis in a physiological (aging) and pathophysiological (transverse aortic constriction [TAC]) mouse model. Methods and Results—: The Cx43 fl/fl and Cx43 CreER(T)/fl mice were aged 18 to 21 months or, at the age of 3 months, either TAC or sham operated and euthanized after 16 weeks. Epicardial activation mapping of the right and left ventricles was performed on Langendorff perfused hearts. Sustained ventricular arrhythmias were induced in 0 of 11 aged Cx43 fl/fl and 10 of 15 Cx43 Cre-ER(T)/fl mice ( P <0.01). Cx43 expression was reduced by half in aged Cx43 CreER(T)/fl compared with aged Cx43 fl/fl mice, whereas collagen deposition was significantly increased from 1.1±0.2% to 7.4±1.3%. Aged Cx43 CreER(T)/fl mice with arrhythmias had significantly higher levels of fibrosis and conduction heterogeneity than aged Cx43 CreER(T)/fl mice without arrhythmias. The TAC operation significantly increased fibrosis in control compared with sham (4.0±1.2% versus 0.4±0.06%), but this increase was significantly higher in Cx43 CreER(T)/fl mice (10.8±1.4%). Discoidin domain receptor 2 expression was unchanged, but procollagen peptide I and III expression and collagen type 1α2 mRNA levels were higher in TAC–operated Cx43HZ mice. Conclusions—: Reduced cellular coupling results in more excessive collagen deposition during aging or pressure overload in mice due to enhanced fibroblast activity, leading to increased conduction in homogeneity and proarrhythmia.